{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T05:37:39Z","timestamp":1738215459714,"version":"3.34.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2008,3,27]],"date-time":"2008-03-27T00:00:00Z","timestamp":1206576000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Z. Rheumatol."],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1007\/s00393-008-0285-6","type":"journal-article","created":{"date-parts":[[2008,3,25]],"date-time":"2008-03-25T15:02:10Z","timestamp":1206457330000},"page":"232-236","source":"Crossref","is-referenced-by-count":3,"title":["Myopathie beim Beh\u00e7et-Syndrom","Myalgia in Neuro-Beh\u00e7et\u2019s disease"],"prefix":"10.1007","volume":"67","author":[{"given":"M.","family":"Kr\u00e4mer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.W.","family":"Baumg\u00e4rtel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Neuen-Jacob","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Berlit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,3,27]]},"reference":[{"key":"285_CR1","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1093\/brain\/122.11.2171","volume":"122","author":"Akman-Demir","year":"1999","unstructured":"Akman-Demir G, Seradaroglu P, Tasci B (1999) Clinical pattern of neurological involvement in Beh\u00e7et\u2019s disease. Brain 122: 2171\u20132181","journal-title":"Brain"},{"key":"285_CR2","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0035-3787(05)85026-X","volume":"161","author":"Ben","year":"2005","unstructured":"Ben Ghorbel I, Ibnelhadj Z, Zouari M et al. (2005) Beh\u00e7et\u2019s disease associated with peripheral neuropathy. Rev Neurol 161: 218\u2013220","journal-title":"Rev Neurol"},{"unstructured":"Berlit P (2005) Zerebrale Vaskulitis \u2013 Beh\u00e7et-Syndrom In: Diener HC et al. (Hrsg) Leitlinien f\u00fcr Diagnostik und Therapie in der Neurologie. Thieme, Stuttgart","key":"285_CR3"},{"doi-asserted-by":"crossref","unstructured":"Berlit P (Hrsg) (2007) Klinische Neurologie. Springer, Berlin Heidelberg New York","key":"285_CR4","DOI":"10.1007\/3-540-31176-9"},{"key":"285_CR5","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1346-8138.2004.tb00531.x","volume":"31","author":"Birol","year":"2004","unstructured":"Birol A, Ulkatan S, Kocak M, Erkek E (2004) Peripheral neuropathy in Beh\u00e7et\u2019s disease. J Dermatol 31: 455\u2013459","journal-title":"J Dermatol"},{"key":"285_CR6","first-page":"45","volume":"40","author":"Budak","year":"2000","unstructured":"Budak F, Efendi H, Apaydin R et al. (2000) The F response parameters in Beh\u00e7et\u2019s disease. Electromyogr Clin Neurophysiol 40: 45\u201348","journal-title":"Electromyogr Clin Neurophysiol"},{"key":"285_CR7","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s002340050742","volume":"41","author":"Coban","year":"1999","unstructured":"Coban O, Bahar S, Akman-Demir G et al. (1999) Masked assessment of MRI findings: is it possible to differentiate neuro-Beh\u00e7et\u2019s disease from other central nervous system? Neuroradiology 41: 255\u2013260","journal-title":"Neuroradiology"},{"key":"285_CR8","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0896-8411(89)80010-1","volume":"2","author":"Cockburn","year":"1982","unstructured":"Cockburn IT, Krupp P (1982) The risk of neoplasms in patients treated with CSA. J Autoimmun 2: 723\u2013731","journal-title":"J Autoimmun"},{"key":"285_CR9","first-page":"333","volume":"33","author":"Duran","year":"2001","unstructured":"Duran E, Chacon JR (2001) Beh\u00e7et\u2019s disease with atypical double neurological involvement. Rev Neurol 33: 333\u2013334","journal-title":"Rev Neurol"},{"key":"285_CR10","first-page":"44","volume":"43","author":"Fujii","year":"2003","unstructured":"Fujii Y, Arimura Y, Takahashi N et al. (2003) A case of Beh\u00e7et\u2019s disease associated with neuromyopathy induced by combination therapy with colchicine and cyclosporine. Ryumachi 43: 44\u201350","journal-title":"Ryumachi"},{"key":"285_CR11","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1136\/ard.53.12.828","volume":"53","author":"Gardner-Medwin","year":"1994","unstructured":"Gardner-Medwin JM, Smith NJ, Powell RJ (1994) Clinical experience with thalidomide in the management of severe oral and genital ulceration in conditions such as Beh\u00e7et\u2019s disease: use of neurophysiological studies to detect thalidomide neuropathy. Ann Rheum Dis 53: 828\u2013832","journal-title":"Ann Rheum Dis"},{"key":"285_CR12","first-page":"154","volume":"189","author":"Gonzales-Gay","year":"1991","unstructured":"Gonzales-Gay MA, Fernandez Camblor B, Sanchez Andrade A et al. (1991) Beh\u00e7et syndrome and peripheral neuropathy as a possible new minor criterion. Rev Clin Esp 189: 154\u2013155","journal-title":"Rev Clin Esp"},{"unstructured":"Hatemi G, Bang D, Bodaghi B et al. Eular Recommendations for the management of Beh\u00e7et\u2019s disease. Speakers presentation. Ann Rheum Dis (Suppl 2) 66: 44","key":"285_CR13"},{"key":"285_CR14","first-page":"1078","volume":"335","author":"International","year":"1990","unstructured":"International Study Group for Beh\u00e7et\u2019s disease (1990) Criteria for Beh\u00e7et\u2019s disease. Lancet 335: 1078\u20131080","journal-title":"Lancet"},{"key":"285_CR15","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1136\/ard.60.1.83","volume":"60","author":"Kotter","year":"2001","unstructured":"Kotter I, Aepinus C, Graepler F et al. (2001) HHV8 associated Kaposi\u2019s sarcoma during triple immunosuppressive treatment with cyclosporin A, azathioprine, and prednisolone for ocular Behcet\u2019s disease and complete remission of both disorders with interferon alpha. Ann Rheum Dis 60: 83\u201386","journal-title":"Ann Rheum Dis"},{"key":"285_CR16","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/s10067-005-0070-8","volume":"25","author":"Kotter","year":"2006","unstructured":"Kotter I, Gunaydin I, Batra M et al. (2006) CNS involvement occurs more frequently in patients with Behcet\u2019s disease under cyclosporin A (CSA) than under other medications \u2013 results of a retrospective analysis of 117 cases. Clin Rheumatol 25: 482\u2013486","journal-title":"Clin Rheumatol"},{"key":"285_CR17","doi-asserted-by":"crossref","first-page":"651","DOI":"10.7326\/0003-4819-116-8-651","volume":"116","author":"Lingenfelser","year":"1992","unstructured":"Lingenfelser T, Duerk H, Stevens A et al. (1992) Generalized myositis in Beh\u00e7et\u2019s diasease: treatment with cyclosporine. Ann Intern Med 116: 651\u2013653","journal-title":"Ann Intern Med"},{"key":"285_CR18","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1136\/ard.61.8.751","volume":"61","author":"Sarui","year":"2002","unstructured":"Sarui H, Maruyama T, Ito I et al. (2002) Necrotising myositis in Beh\u00e7et\u2019s disease: characteristic features on magnetic resonance imaging and a review of the literature. Ann Rheum Dis 61: 751\u2013752","journal-title":"Ann Rheum Dis"},{"key":"285_CR19","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s004310051320","volume":"159","author":"Uziel","year":"2000","unstructured":"Uziel Y, Lazarov A, Cordoba M, Wolach B (2000) Pediatric Beh\u00e7et disease manifesting as recurrent myositis: from an incomplete to a full-blown form. Eur J Pediatr 159: 507\u2013508","journal-title":"Eur J Pediatr"},{"key":"285_CR20","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0960-8966(96)00019-3","volume":"6","author":"Worthmann","year":"1996","unstructured":"Worthmann F, Bruns J, Turker T, Gosztonyi G (1996) Muscular involvement in Beh\u00e7et\u2019s disease: case report and review of the literature. Neuromuscul Disord 6: 247\u2013253","journal-title":"Neuromuscul Disord"},{"key":"285_CR21","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/art.1780240412","volume":"24","author":"Yazici","year":"1981","unstructured":"Yazici H, Tuzuner N, Tuzun Y, Yurdakul S (1981) Localized myositis in Beh\u00e7et\u2019s diasease. Arthritis Rheum 24: 636","journal-title":"Arthritis Rheum"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-008-0285-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00393-008-0285-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-008-0285-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T16:35:55Z","timestamp":1559061355000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00393-008-0285-6"}},"subtitle":["Medikamentennebenwirkung oder Ausdruck der Grunderkrankung?","Medication side effects or expression of underlying disease"],"short-title":[],"issued":{"date-parts":[[2008,3,27]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["285"],"URL":"https:\/\/doi.org\/10.1007\/s00393-008-0285-6","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"type":"print","value":"0340-1855"},{"type":"electronic","value":"1435-1250"}],"subject":[],"published":{"date-parts":[[2008,3,27]]}}}